With biologic drugs becoming more prominent in the marketplace, protein engineers are now turning their attention to new indications, improved targeting, new formats and products that are truly differentiated relative to competitors. The Protein Engineering & Development pipeline offers a weeklong exploration of state-of-the-art approaches for developing safe and effective protein and antibody-based therapeutics.
Recombinant Protein Therapeutics
Enhancing Antibody Binding and Specificity
Improving the Clinical Efficacy of Antibody Therapeutics
RECOMMENDED DINNER SHORT COURSES*
SC1: Production Challenges for Complex Biologics: ADCs, Bispecifics and Fusion Proteins
SC7: Targeting of GPCRs with Monoclonal Antibodies
*Separate registration required. Click here for more details